3 Penny Stocks Making Interesting Moves With High Volume in October $RESN $PESI $LXRX
3 Penny Stocks Making Interesting Moves With High Volume
One of the biggest attractions to penny stocks is the fact that these stocks have the potential of generating enormous profits. Not only that but these profits typically come from a relatively small investment.Since cheap stocks generally trade below $5 a share, it is possible for an investor to buy a large number of shares. Furthermore, some penny stocks are so low priced, investors can buy millions of shares for hundreds of dollars.

If the stock then moves in the right direction there could be a hefty profit in tow. So if you wonder, “are penny stocks are worth it,” that depends on who you ask. For novice investors using penny stocks like lottery tickets, the answer is likely no. But for experienced investors who understand trading, the answer is likely yes.
However, it’s not easy to get hold of such stocks so you need to conduct research. If you go into a trade without a plan, then plan on losing. Sure, you might get lucky but luck shouldn’t have a place in your plan to make money with penny stocks. Here is a look at three penny stocks that went big this month so far.
Best Penny Stocks #1: Resonant Inc. (RESN)
The first penny stock to watch is Resonant Inc (RESN Stock Report), which enjoyed impressive gains on Wednesday. This came after it announced the agreement of an important deal. Resonant is involved in changing the ways in which radiofrequency front ends are designed. Yesterday, it announced that it had reached an agreement with radiofrequency and module provider Murata Manufacturing Co.
Best Penny Stocks #2: Perma-Fix Environmental (PESI)
Another one of the penny stocks to watch that has been on a roll is Perma-Fix Environmental Services, Inc. (PESI Stock Report). Back on September 24, the company announced that it had reached an agreement to work on nuclear service projects.
Best Penny Stocks #3: Lexicon Pharmaceuticals (LXRX)
Last but not least; Lexicon Pharmaceuticals, Inc. (LXRX Stock Report). Shares of LXRX stock have been on a tear for around a month. This was ever since terminating its partnership agreement with Sanofi. The termination gave Lexicon full control over its diabetes product Zynquista and in addition to that, Sanofi is going to pay the company as much as $260 million as a parting shot.
Like This Article? Check Out 3 Penny Stocks To Buy Or Sell Before Friday?
* This article was originally published here
Post a Comment